NCT00578786 - A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202) | Biotech Hunter

Enrollment

383

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG

ambrisentan

2.5, 5.0 or 10.0 mg ambrisentan po, qd, long-term

Trial Locations (22)

14080

Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City

64718

Unidad De Investigacion Clinica en Medicina, Monterrey, Nuevo Leon

C1115AAB

Sanatorio Otamendi, Ciudad Autonoma de Buenos Aires

C1280AEB

Hospital Britanico-Buenos Aires, Ciudad Autonoma de Buenos Aires

C1416A

Instituto del Corazon Denton A. Cooley, Ciudad Autonoma de Buenos Aires

C1437BZL

UAI Hosp. Universitario, Ciudad Autonoma de Buenos Aires

07600

HIGA Hospital Interzonal General de Agudos Oscar Allende, Mar del Plata

01605

Clinica Independencia Munro, Munro

W3400AMZ

Instituto de Cardiologia J.F. Cabral, Corrientes

X5000JHQ

Sanatorio Allende, Córdoba

X5004 FJE

Hospital Italiano de Cordoba, Córdoba

02000

Hospital Italiano de Rosario, Rosario

X5016KEH

Hospital Privado Centro Medico de Cordoba, Córdoba

21941-590

Hospital Universitario Clementino Fraga Filho, Ilha Do Fundao

30380-090

Hospital Madre Teresa, Belo Horizonte

90610-000

Hospital San Lucas de Pontificia Universidade Catolica, Porto Alegre

92020-090

Complexo Hospitalar Sanata Casa de Porto Alegre, Porto Alegre

04023-062

Universidade do Estado de Sao Paulo - UNIFESP, São Paulo

05403-000

Hospital das Clinicas da FMUSP, São Paulo

CP 8330024

Hospital San Juan de Dios, Santiago

CP 8350488

Hospital Clinico Universidad Catolica, Santiago

CP7500691

Instituto Nacional del Torax, Santiago